The store will not work correctly when cookies are disabled.
1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)-3-(3,4-difluorophenyl)urea
ID: ALA2409113
Chembl Id: CHEMBL2409113
PubChem CID: 71812410
Max Phase: Preclinical
Molecular Formula: C19H16F2N4O
Molecular Weight: 354.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(F)c(F)c1)Nc1cc(C2CC2)nn1-c1ccccc1
Standard InChI: InChI=1S/C19H16F2N4O/c20-15-9-8-13(10-16(15)21)22-19(26)23-18-11-17(12-6-7-12)24-25(18)14-4-2-1-3-5-14/h1-5,8-12H,6-7H2,(H2,22,23,26)
Standard InChI Key: WYIBZKHKGMRACH-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.36 | Molecular Weight (Monoisotopic): 354.1292 | AlogP: 4.67 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.95 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.31 | CX Basic pKa: 1.95 | CX LogP: 4.49 | CX LogD: 4.49 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -2.35 |
References
1. Wen W, Wu W, Romaine IM, Kaufmann K, Du Y, Sulikowski GA, Weaver CD, Lindsley CW.. (2013) Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors., 23 (16): [PMID:23838260] [10.1016/j.bmcl.2013.06.023] |